Stay updated on KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page.

Latest updates to the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.3 was added to the page, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history shows a UI version update: v3.3.2 has been added and v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding lapse notice at the top of the page was removed. This change does not affect the trial data or registered study details.SummaryDifference0.5%

- Check54 days agoChange DetectedLatest record history version shows an update to the Study Status and Recruitment Status for NCT04738123, reflecting a change in the trial's current phase and enrollment. The update is visible in the version history alongside prior entries.SummaryDifference0.1%

- Check82 days agoChange DetectedUpdate includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.SummaryDifference11%

- Check90 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content appears to be altered.SummaryDifference0.3%

Stay in the know with updates to KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page.